C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China’s MAH Framework

CHENGDU, China, June 25, 2026 /PRNewswire/ — On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel of experts from the Sichuan Provincial Center for Drug Evaluation and the National Defense…

Read the full release →

News provided by PR Newswire.